Chat with GenHealth to automate any coding or chart task.
Name of the Procedure:
Common Name: Injection of Polatuzumab Vedotin
Technical Term: Injection, polatuzumab vedotin-piiq, 1 mg (HCPCS J9309)
Summary
Injection of Polatuzumab Vedotin is a medical treatment involving the administration of a drug used primarily for certain types of cancer. It's a targeted therapy designed to attack cancer cells.
Purpose
Medical Conditions: This treatment is mainly used for aggressive forms of B-cell lymphoma, such as diffuse large B-cell lymphoma (DLBCL).
Goals: The goal is to reduce the size of the cancer, alleviate symptoms, and possibly achieve remission.
Indications
Symptoms/Conditions: Patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
Criteria: Suitable for adult patients who have already tried other treatments without success.
Preparation
Instructions: Patients might be advised to avoid certain medications, follow dietary restrictions, or hydrate well before the procedure.
Diagnostics: Pre-treatment blood tests, imaging scans, or biopsies to assess the patient’s condition and suitability.
Procedure Description
- Step-by-Step:
- Assessment and preparation by a nurse or doctor.
- An intravenous (IV) line is inserted into the patient's vein.
- Polatuzumab Vedotin is infused slowly through the IV.
- Monitoring for any immediate side effects.
- Tools/Equipment: IV line, infusion pump, and necessary monitoring equipment.
- Anesthesia/Sedation: Generally not required unless specified for pain management or comfort.
Duration
The infusion typically takes about 30-90 minutes, depending on dosage and specific patient needs.
Setting
Usually performed in a hospital or an outpatient clinic with facilities for chemotherapy administration.
Personnel
Healthcare professionals involved:
- Oncologist or Hematologist
- Oncology Nurse
- Pharmacist
- Possibly a medical assistant or technician
Risks and Complications
Common Risks: Fatigue, nausea, peripheral neuropathy, and possible infusion reactions like rash or fever.
Rare Risks: Severe infections, allergic reactions, or organ toxicity. Immediate medical attention is available to manage these complications.
Benefits
Expected Benefits: Reduction in tumor size, symptom relief, potential progression to remission.
Timeframe: Benefits may be noticeable within several weeks to a few months, depending on individual response.
Recovery
Post-Procedure Care: Follow-up appointments to monitor response and side effects, medication for side effect management, possible dietary and activity restrictions.
Recovery Time: Varies; patients may expect some side effects to persist for days to weeks.
Alternatives
Other Options: Alternative chemotherapy regimens, radiotherapy, targeted therapies, or stem cell transplant.
Pros and Cons: Each alternative has different effectiveness, side effect profiles, and suitability depending on the patient's condition.
Patient Experience
During the Procedure: Patients may feel slight discomfort from the IV insertion and possible mild infusion reactions.
After the Procedure: Expect fatigue and possible nausea; pain management strategies and comfort measures will be employed to ease symptoms. Regular follow-ups will be conducted to monitor the patient's health and response to treatment.
Medical Policies and Guidelines
Related policies from health plans
J9309 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.